Prostate cancer is one of the most common forms of cancer in the world, but not only does it put the lives of those diagnosed at risk, but can also severely impact patient quality of life due to ...

Please provide your email address to receive an email when new articles are posted on . Exercise 3 days a week conferred more benefit than usual care for men with prostate cancer and erectile ...

A phase I/II trial of enzalutamide plus the glucocorticoid receptor antagonist mifepristone for patients with metastatic castration-resistant prostate cancer (mCRPC). Background: Provocative evidence ...

Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma Androgen-deprivation therapy ...